MARKET

ATRC

ATRC

Atricure
NASDAQ
23.04
-0.10
-0.43%
Opening 12:20 05/20 EDT
OPEN
23.02
PREV CLOSE
23.14
HIGH
24.02
LOW
22.69
VOLUME
259.75K
TURNOVER
0
52 WEEK HIGH
59.61
52 WEEK LOW
20.19
MARKET CAP
1.11B
P/E (TTM)
-28.7856
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ATRC last week (0513-0517)?
Weekly Report · 8h ago
Pulse Biosciences Stock: Signs Of Life Following Q1 Update
FDA has cleared the company's percutaneous electrode system for use in soft tissue ablation. The surgical clamp device for cardiac indications is still in the preclinical trial phase. Pulse Biosciences is making progress in its commercialization strategy. The company's stock is down more than 40% year to date.
Seeking Alpha · 3d ago
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
AtriCure, Inc. Will participate in the Leerink Partners Healthcare Crossroads Conference on May 29, 2024. The company is a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib) and left atrial appendage management. AtriCures management is scheduled to participate in a fireside chat.
Barchart · 5d ago
AtriCure Enhances Governance and Expands Stock Plan
TipRanks · 5d ago
Weekly Report: what happened at ATRC last week (0506-0510)?
Weekly Report · 05/13 11:39
Weekly Report: what happened at ATRC last week (0429-0503)?
Weekly Report · 05/06 11:47
AtriCure Is Maintained at Buy by Canaccord Genuity
Dow Jones · 05/02 19:20
AtriCure Price Target Cut to $49.00/Share From $57.00 by Canaccord Genuity
Dow Jones · 05/02 19:20
More
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Webull offers AtriCure Inc stock information, including NASDAQ: ATRC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATRC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATRC stock methods without spending real money on the virtual paper trading platform.